Given that increased VEGFR expression has been found in the microvascular endothelial cells of ATC tumor specimens,[13] agents targeting VEGFR can block the effects of vascular endothelial growth factors and play antiangiogenic and antitumor roles in solid tumors. The gene discussed is KDR; the disease is neoplasm.